267 related articles for article (PubMed ID: 36978995)
1. Involvement of Intracellular TAGE and the TAGE-RAGE-ROS Axis in the Onset and Progression of NAFLD/NASH.
Sakasai-Sakai A; Takeda K; Takeuchi M
Antioxidants (Basel); 2023 Mar; 12(3):. PubMed ID: 36978995
[TBL] [Abstract][Full Text] [Related]
2. Intracellular Toxic Advanced Glycation End-Products Promote the Production of Reactive Oxygen Species in HepG2 Cells.
Sakasai-Sakai A; Takata T; Takeuchi M
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32660150
[TBL] [Abstract][Full Text] [Related]
3. The Relevance of Toxic AGEs (TAGE) Cytotoxicity to NASH Pathogenesis: A Mini-Review.
Sakasai-Sakai A; Takata T; Takino JI; Takeuchi M
Nutrients; 2019 Feb; 11(2):. PubMed ID: 30813302
[TBL] [Abstract][Full Text] [Related]
4. Intracellular Toxic AGEs (TAGE) Triggers Numerous Types of Cell Damage.
Takeuchi M; Sakasai-Sakai A; Takata T; Takino JI; Koriyama Y; Kikuchi C; Furukawa A; Nagamine K; Hori T; Matsunaga T
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33808036
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategies.
Takeuchi M; Takino J; Sakasai-Sakai A; Takata T; Ueda T; Tsutsumi M; Hyogo H; Yamagishi S
World J Hepatol; 2014 Dec; 6(12):880-93. PubMed ID: 25544875
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of toxic AGEs (TAGE) may be a promising novel biomarker in development and progression of NASH.
Takeuchi M; Sakasai-Sakai A; Takata T; Ueda T; Takino J; Tsutsumi M; Hyogo H; Yamagishi S
Med Hypotheses; 2015 May; 84(5):490-3. PubMed ID: 25697114
[TBL] [Abstract][Full Text] [Related]
7. Contribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinoma.
Takino J; Nagamine K; Hori T; Sakasai-Sakai A; Takeuchi M
World J Hepatol; 2015 Oct; 7(23):2459-69. PubMed ID: 26483867
[TBL] [Abstract][Full Text] [Related]
8. Serum Levels of Toxic AGEs (TAGE) May Be a Promising Novel Biomarker for the Onset/Progression of Lifestyle-Related Diseases.
Takeuchi M
Diagnostics (Basel); 2016 Jun; 6(2):. PubMed ID: 27338481
[TBL] [Abstract][Full Text] [Related]
9. Toxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALD.
Takeuchi M; Takino JI; Sakasai-Sakai A; Takata T; Tsutsumi M
Nutrients; 2017 Jun; 9(6):. PubMed ID: 28632197
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of Toxic Advanced Glycation End-Products Induces Cytotoxicity and Inflammation in Hepatocyte-Like Cells Differentiated from Human Induced Pluripotent Stem Cells.
Kikuchi C; Sakasai-Sakai A; Okimura R; Tanaka H; Takata T; Takeuchi M; Matsunaga T
Biol Pharm Bull; 2021; 44(10):1399-1402. PubMed ID: 34602548
[TBL] [Abstract][Full Text] [Related]
11. Toxic AGEs (TAGE) theory: a new concept for preventing the development of diseases related to lifestyle.
Takeuchi M
Diabetol Metab Syndr; 2020 Nov; 12(1):105. PubMed ID: 33292465
[TBL] [Abstract][Full Text] [Related]
12. Evidence for Toxic Advanced Glycation End-Products Generated in the Normal Rat Liver.
Takata T; Sakasai-Sakai A; Takino JI; Takeuchi M
Nutrients; 2019 Jul; 11(7):. PubMed ID: 31315223
[TBL] [Abstract][Full Text] [Related]
13. Potential of an Interorgan Network Mediated by Toxic Advanced Glycation End-Products in a Rat Model.
Inoue S; Takata T; Nakazawa Y; Nakamura Y; Guo X; Yamada S; Ishigaki Y; Takeuchi M; Miyazawa K
Nutrients; 2020 Dec; 13(1):. PubMed ID: 33383715
[TBL] [Abstract][Full Text] [Related]
14. Increase of α-dicarbonyls in liver and receptor for advanced glycation end products on immune cells are linked to nonalcoholic fatty liver disease and liver cancer.
Petriv N; Neubert L; Vatashchuk M; Timrott K; Suo H; Hochnadel I; Huber R; Petzold C; Hrushchenko A; Yatsenko AS; Shcherbata HR; Wedemeyer H; Lichtinghagen R; Falfushynska H; Lushchak V; Manns MP; Bantel H; Semchyshyn H; Yevsa T
Oncoimmunology; 2021 Feb; 10(1):1874159. PubMed ID: 33628620
[TBL] [Abstract][Full Text] [Related]
15. Suppression of Hepatic Stellate Cell Death by Toxic Advanced Glycation End-Products.
Takino JI; Sato T; Nagamine K; Sakasai-Sakai A; Takeuchi M; Hori T
Biol Pharm Bull; 2021; 44(1):112-117. PubMed ID: 33390537
[TBL] [Abstract][Full Text] [Related]
16. Structures of Toxic Advanced Glycation End-Products Derived from Glyceraldehyde, A Sugar Metabolite.
Sakai-Sakasai A; Takeda K; Suzuki H; Takeuchi M
Biomolecules; 2024 Feb; 14(2):. PubMed ID: 38397439
[TBL] [Abstract][Full Text] [Related]
17. Effects of Toxic AGEs (TAGE) on Human Health.
Takeuchi M; Sakasai-Sakai A; Takata T; Takino JI; Koriyama Y
Cells; 2022 Jul; 11(14):. PubMed ID: 35883620
[TBL] [Abstract][Full Text] [Related]
18. Intracellular Toxic Advanced Glycation End-Products in 1.4E7 Cell Line Induce Death with Reduction of Microtubule-Associated Protein 1 Light Chain 3 and p62.
Takata T; Sakasai-Sakai A; Takeuchi M
Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057513
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the toxic AGEs (TAGE)-RAGE system in the pathogenesis of diabetic vascular complications: a novel therapeutic strategy.
Takeuchi M; Takino J; Yamagishi S
Curr Drug Targets; 2010 Nov; 11(11):1468-82. PubMed ID: 20583971
[TBL] [Abstract][Full Text] [Related]
20. Impact of intracellular toxic advanced glycation end-products (TAGE) on murine myoblast cell death.
Takata T; Sakasai-Sakai A; Takeuchi M
Diabetol Metab Syndr; 2020; 12():54. PubMed ID: 32684984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
